Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-09

Clinical Trial Update: Effect of Self-administered tDCS in Patients With MDD [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating self-administered transcranial direct current stimulation in patients with major depressive disorder has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Self-administered transcranial direct current stimulation

Snippet

Sponsor: Jeong-Ho Chae | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED